KAREN CRIMINGER: Open Payments
NPI 1801807904 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 23 payments from 11 companies in 2025. Trend: 2023 $307 · 2024 $342 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 2 | $52 |
| Eisai Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Verona Pharma, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, ELIQUIS, Leqembi, REXULTI, Ohtuvayre, GVOKE HYPOPEN, ACCRUFER.
Industry payments across NC — which companies pay providers there.
